Prognostic Value of Lung Cancer MicroAnatomy in 3D
NCT05565677 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2022-10-04
Summary
Micro-computed tomography (micro-CT) is a novel biomedical non-destructive, slide-free digital imaging modality, which enables the rapid acquisition of accurate high-resolution, volumetric images of intact surgical tissue specimens. This imaging modality provides microscopic level of detail of intact tissues in three-dimensions without requiring any specimen preparation. Its non-destructive nature and the ongoing enhancement of imaging resolution and contrast renders micro-CT imaging particularly well suited for microanatomic studies in basic research across a wide range of interventional medical disciplines, including oncology.
Our proposal concerns a multidisciplinary basic research effort which aims to facilitate the effective identification of different -and maybe challenging to differentiate- lung cancer patterns based on 3D X-ray histology. As an alternative for the use of hematoxylin \& eosin (H\&E) slides, optimized micro-CT scanning of soft tissues emerges as a promising tool to enable non-invasive 3D X-ray histology of formalin-fixed and paraffin-embedded (FFPE) lung cancer specimens.
The objective of our proposal is to offer novel insights into the complex architecture of each lung cancer subtype after imaging FFPE surgical specimens, resected from lung cancer surgeries. The investigators aim to generate 3D datasets of FFPE lung cancer tissues which will be combined with the corresponding conventional 2D histology slides. Our study will be also adequately empowered to identify particular differences in morphometric measurements according to each particular lung cancer growth pattern.
Finally, this proposal aims to delineate the different 3D microanatomy and morphology of some patterns that are challenging to interpret and differentiate through traditional 2D histological evaluation, such as papillary and lepidic adenocarcinoma growth patterns.
Classification of the histological subtypes based on 2D histology sections can be ambiguous, as shown by suboptimal inter-observer consensus when determining predominant histological subtypes in FFPE lung adenocarcinoma tissue specimens. Hence, micro-CT-based 3D imaging of the lung specimens could aid classification of histological subtypes by providing more comprehensive sampling of the entire tissue block and yielding detail relevant for subtype classification that might not be visible in 2D sections alone.
Conditions
- Lung Cancer
- Adenocarcinoma of Lung
- Pathology
- Micro-computed Tomography
- X-ray Histology
- Digital Pathology
Interventions
- DEVICE
-
micro-computed tomography scanning of lung tissue specimens
Micro-computed tomography will be utilized to scan surgically resected lung tissue specimens.
Sponsors & Collaborators
-
National and Kapodistrian University of Athens
collaborator OTHER -
University of Southampton
collaborator OTHER -
Aristotle University Of Thessaloniki
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-10-01
- Primary Completion
- 2024-10-01
- Completion
- 2025-10-01
- FDA Device
- Yes
More Related Trials
-
Recurrent Predictive Power of Circulating Tumor Cells for Non Small Cell Lung Cancer Patients
NCT03721133 ·Status: ENROLLING_BY_INVITATION
-
Single-Cell Sequencing Analysis of Radiation Pneumonitis Signals In Patients Treated For Cancer With Radiotherapy
NCT06557343 ·Status: RECRUITING
-
Radiomics and Radiogenomics of Non-small Cell Lung Cancer
NCT06331975 ·Status: COMPLETED ·Phase: NA
-
Multiparametric Image Analysis and Correlation With Outcomes in Lung Cancer Screening and Early Stage Lung Cancer
NCT03563976 ·Status: RECRUITING
-
Construction of CT Radiomics Model for Predicting the Efficacy of Immunotherapy in Patients With Stage III NSCLC
NCT04984148 ·Status: UNKNOWN
-
Early Stage Lung Cancer Screening With Low-dose Computed Tomographic
NCT02898441 ·Status: UNKNOWN ·Phase: NA
-
Novel Detection System for Lung Cancer Curative Effect Monitoring
NCT02666755 ·Status: UNKNOWN
-
Thoracic Re-irradiation For Locoregionally Recurrent Non-small Cell Lung Cancer
NCT04275687 ·Status: UNKNOWN ·Phase: PHASE2
-
Analysis of the Microenvironment of Lung Cancer and Exploration of the Mechanism of Resistance to Immunotherapy
NCT05636605 ·Status: RECRUITING
-
Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer
NCT07035860 ·Status: NOT_YET_RECRUITING
-
Construction and Evaluation of the Liquid Biopsy-based Early Diagnostic Model for Lung Cancer
NCT04156360 ·Status: UNKNOWN
-
Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery
NCT05648370 ·Status: UNKNOWN
-
Multiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer
NCT07057102 ·Status: RECRUITING
-
Retrospective Epidemiological Study of Lung Cancer With Low-dose Multislice Computed Tomography
NCT02736643 ·Status: COMPLETED
-
Low-dose Protocol for Computed Tomography-guided Lung Biopsy
NCT02971176 ·Status: COMPLETED ·Phase: NA
-
The Role of Interventional Pulmonology, Microbiota and Immune Response in the Patient With Lung Cancer
NCT05164445 ·Status: COMPLETED ·Phase: NA
-
Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01517971 ·Status: COMPLETED
-
Application of Detecting Circulating Tumor Cells in the Accurate Treatment of Early Stage Lung Adenocarcinoma
NCT02951897 ·Status: UNKNOWN ·Phase: NA
-
Proton Therapy to Reduce Acute Normal Tissue Toxicity in Locally Advanced Non-small-cell Lung Cancer
NCT02731001 ·Status: RECRUITING ·Phase: NA
-
Study of Early Cancer Biomarkers in Breath Condensate in Population of Individuals With High-Risk of Lung Cancer Undergoing LDCT Screening.
NCT06016569 ·Status: RECRUITING ·Phase: NA
-
Visualising c-MET and Activated Neutrophils in Lung Cancer
NCT02676050 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Early Intervention Strategies for Lung Cancer
NCT06988943 ·Status: RECRUITING ·Phase: NA
-
The Detection Of Circulating Tumor Cells (CTC) In Patients With NSCLC Undergoing Definitive Radiotherapy Or Chemoradiotherapy
NCT02135679 ·Status: COMPLETED
-
Screening for Lung Cancer in Subjects With Family History of Lung Cancer
NCT05762731 ·Status: RECRUITING
-
LDCT Screening in Non-smokers in Taiwan
NCT02611570 ·Status: ACTIVE_NOT_RECRUITING